Patrick Abt is a Cardiology physician affiliated with Rochester General Hospital. OpenAlex indexes 9 publications with 352 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20252 payments
- Inspire Medical Systems, Inc.Program year20251 payment
- Inspire Medical Systems, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.8%Beta blocker23.2%Metoprolol Succinate70%Carvedilol14%Metoprolol Tartrate11%Atenolol6%Part D<11 patientsStatin19%Atorvastatin Calcium58%Rosuvastatin Calcium42%Part D≥62 patients+ 11 more classes in this area
Metabolism & gastrointestinal
7.7%SGLT2 inhibitor7.7%Farxiga67%Jardiance33%Part D≥16 patientsBlood & clotting
6.5%Factor Xa inhibitor4.1%Eliquis100%Part D≥21 patientsP2Y12 inhibitor2.4%Clopidogrel68%Brilinta32%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- EARLY DIAGNOSIS OF AN UNDERRECOGNIZED SYNDROME PREVENTING IMPENDING SHOCK IN THE SETTING OF SEPSIS: BRASH SYNDROME
Journal of the American College of Cardiology
2024 - A CASE OF LEFT ATRIAL COMPRESSION CAUSING MECHANICAL TAMPONADE THROUGH MASSIVE ENDOLEAK OF THE THORACIC AORTA
Journal of the American College of Cardiology
2024 - Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy
The American Journal of Cardiology
2018 - THE IMPACT OF ADVANCED THERAPIES IN IMPROVING SURVIVAL TO HEART TRANSPLANT IN HYPERTROPHIC CARDIOMYOPATHY
Journal of the American College of Cardiology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Pichichero, MD
Rochester General Hospital
Farhad Abtahian
Rochester General Hospital
Pradyumna Phatak, MD
Rochester General Hospital
Louis Eichel, MD
Rochester General Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”